The world is talking about ending AIDS. AVAC’s advocacy is dedicated to realizing that vision. To get there we must:
Happy New Year! We hope that you started your year refreshed for important work ahead–and to help get you started, we’ve rounded up a few select resources from AVAC.org that we hope you’ll consider as you set your agenda for 2019. We think these cross-cutting and thought-provoking tools help to frame the most pressing issues facing HIV prevention in the year ahead.
Is HIV prevention research seeing its last placebo-controlled efficacy trials? Will the field have to radically reimagine how to answer efficacy questions?
As 2018 comes to an end, AVAC extends gratitude to all HIV prevention advocates—those we work with, those whose names we do not know—for the hope and fierce commitment that you bring to the work every day.
In this episode of Px Pulse, we consider how future HIV prevention trials will need to be designed as HIV prevention evolves... and how to strengthen community engagement along with it. At the heart of the matter is that clinical trials for HIV prevention are set to get bigger and more complex, in response to advances in HIV prevention, such as PrEP.
AVAC has an extensive online resource library with hundreds of Reports, Publications, Infographics & more. And it includes powerful search features to find exactly what you’re looking for.
AVAC uses education, policy analysis, advocacy, community mobilization and a network of global collaborations to accelerate ethical development and global delivery of biomedical HIV prevention options. Read more
AVAC advocates for a comprehensive response to the epidemic, involving smart use of every proven HIV prevention option available today and sustained research into many new strategies.